Design Therapeutics Inc (DSGN) returns
Design Therapeutics returns over 5 years
$1,000 invested in Design Therapeutics five years ago was worth $681.12 at the close on October 30, 2026, with dividends reinvested: an average return of -7.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -15.0% | — | $849.64 | -0.9% |
| 3 months | -15.4% | — | $846.28 | +2.1% |
| Year to date | +13.9% | — | $1,139 | +11.7% |
| 1 year | +63.6% | — | $1,636 | +12.4% |
| 3 years | +423.5% | +73.6% | $5,235 | +88.5% |
| 5 years | -31.9% | -7.4% | $681.12 | +76.0% |
Design Therapeutics return by calendar year
| Year | DSGN | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +13.9% | +11.7% | +2.2% |
| 2025 | +52.0% | +17.7% | +34.3% |
| 2024 | +132.8% | +24.9% | +107.9% |
| 2023 | -74.2% | +26.2% | -100.4% |
| 2022 | -52.1% | -18.2% | -33.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Design Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.